GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Compound class:
Synthetic organic
Comment: IAMA-6 is a small molecule inhibitor of the basolateral Na-K-Cl symporter NKCC1 (SLC12A2). The chemical structure was disclosed during the 'First Time disclosures' session at the ACS Spring 2025 meeting in San Diego and this was matched to ARN23746/compound 1 in [1]. IAMA-6 is intended as an orally bioavailable agent that targets NKCC1-associated neuronal hyperexcitability as a mechanism to restore neuronal excitability as a treatment for neurological disorders, including autism and epilepsies in paediatric patients.
|
|
Bioactivity Comments |
Rescues core neurological symptoms in rodent models of Down syndrome and autism [1]. Inhibits NKCC1-mediated Cl- influx by >85% at 100 μM, and Ca2+ influx by ~90% at the same concentration. Does not inhibit kidney-specific NKCC2 (SLC12A1) in the Cl- influx assay. |
Selectivity at transporters | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|